NeuroDerm CEO to Present at Upcoming Investor Conferences
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/11/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
- Houthi strike on Saudi airport kills 12, worst attack on kingdom in a decade
- US consumer sentiment near record low as frustration over economy mounts
- 8.0 Mag. Earthquake 14 Km Sw Of Pitaloza Arriba Panama - USGS
- Strong Panama quake shakes nation, but avoids major destruction
- Nio stock jumps after Goldman Sachs upgrade to buy
Neuroderm Ltd (NDRM) PT Raised to $70 at Cowen; Could Transform Late Stage Parkinson's Care
March 1, 2017 3:44 PM ESTCowen raised its price target on Neuroderm Ltd (NASDAQ: NDRM) to $70.00 (from $38.00) while maintaining a Outperform rating, saying it could transform late stage Parkinson's care.
Analyst Ken Cacciatore commented, "Neuroderm announced the preliminary Phase II results for ND0612H, and importantly, the... More



